No Cellphone, Brain Cancer Link; Testosterone Paradox; Breast Density and Cancer

— News, features, and commentary about cancer-related issues

MedicalToday
Onco Break over a computer rendering of a cancer cell.

A WHO review of 63 studies found no evidence of an association between prolonged . (Washington Post)

CDK4/6 inhibitors, best known for use in breast cancer, may have activity in a type of . (Dana-Farber Cancer Institute, Cancer Cell)

Another win for artificial intelligence, this time for detection of related to cancer immunotherapy. (Mass General Brigham, Journal of Clinical Oncology)

New insights into testosterone's in prostate cancer. (Duke Health, Nature Communications)

A review of nearly 40 years of prostate cancer data showed rapid increases in incidence throughout Europe with little change in prostate cancer mortality, . (The BMJ)

No for oncologists -- say oncologists. (Oncology News Central)

A against Walgreens alleges the drugstore giant sold a generic version of the cold medicine Mucinex that contained the cancer-causing chemical benzene. (Reuters)

Questions about the FDA's new regulation about ? The American College of Surgeons and the National Accreditation Program for Breast Centers have answers.

A can improve the chances that older patients with cancer receive optimal care, according to two recent publications. (University of Rochester Medical Center)

The search continues for an explanation for the among Asian American and Pacific Islander women. (CBS News)

might be inaccurate in nearly 80% of cases, emphasizing the need for better diagnostic and staging technology to help improve treatment and outcomes. (Cedars-Sinai Cancer, JAMA)

  • author['full_name']

    Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. He joined in 2007.